Chardan Healthcare Acquisition 2 Corp.
Status: Deal Closed
U=S+W
W=S/2@11.5
IPO Proceeds, $M | $86.23M |
---|---|
IPO Date | Apr 24, 2020 |
CEO | Jonas Grossman |
Left Lead | Chardan |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
Healthcare in North America |
IPO Geography | US/Canada |
Target Company | Renovacor Inc |
Deal Announced | Mar 23, 2021 |
Deal Size, $M | $84.60M |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings | www.sec.gov |
Approval Vote | Sep 1, 2021 |
Amendment Vote | TBD |
Closing Date | Sep 2, 2021 |
Formerly CHAQ
RCOR
RCOR/W
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Chardan Healthcare Acquisition 2 Corp.:
- Structure and cap table
- 9 directors & officers
- 19 filings and events
- 2 underwriters
- 2 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Gbola Amusa | 45 | Executive Chairman of the Board & Chief Science Officer |
Jonas Grossman | 45 | President, CEO & Director |
George Kaufman | 42 | CFO, Head of Strategy & Director |
Guy Barudin | 59 | COO |
Isaac Manke | 42 | Director |
Michael Rice | 53 | Director |
Richard Giroux | 46 | Director |
Matthew Rossen | 41 | Director |
R.A. Session II | 41 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Chardan | BR | 8,450,000 | units |
B. Riley FBR | 50,000 | ||
8,500,000 | units | ||
Up-Front UW fee | 0.58 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 19 filings.